Objectives: To describe a novel plasmid-borne class D carbapenemase (CHDL) named OXA-427 identified in several Enterobacteriaceae clinical isolates from nine patients in one Belgian hospital.
Introduction
Ambler class D b-lactamases constitute a large and diverse group of b-lactamases frequently identified in clinically relevant Gramnegative bacteria either as intrinsic chromosomally encoded b-lactamases in certain species or as acquired b-lactamases associated with mobile genetic elements. 1, 2 These enzymes exhibit a high degree of sequence diversity and various hydrolysis activities toward b-lactams. 1 Among Ambler class D b-lactamases, several enzymes possess a carbapenemase activity and are commonly named carbapenem-hydrolysing class D b-lactamases (CHDLs). Most often CHDLs are restricted to a few bacterial genera. Accordingly, OXA-23, OXA-24/40, OXA-58, OXA-143 and OXA-235 are mostly found in Acinetobacter, OXA-198 is still restricted to Pseudomonas aeruginosa and the predominant acquired CHDLs in Enterobacteriaceae belong to the OXA-48 family.
Since the first identification of OXA-48 in a Klebsiella pneumoniae isolate in Turkey, 3 OXA-48-like enzymes have become the predominant carbapenemases in Enterobacteriaceae in many areas and V C The Author 2017. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please email: journals.permissions@oup.com. countries worldwide. 4, 5 To date, several OXA-48-like closely related variants have been reported in Enterobacteriaceae. They include: (i) true carbapenemases with hydrolytic activity against penicillins and carbapenems (but not extended-spectrum cephalosporins) (e.g. OXA-162, -181, -204, -232, -244, -245, -370 and others), and (ii) a few variants devoid of any carbapenemase activity but displaying high activity against extended-spectrum cephalosporins (e.g. OXA-163, -247, -405 and others) due to amino acid deletions in the active site of the enzyme. [6] [7] [8] [9] The natural reservoir of the OXA-48-like genes has been identified within Shewanella species (e.g. S. oniedensis or S. xiamenensis), an environmental and non-human-pathogenic microorganism. 3 Recently a novel plasmid-encoded CHDL, OXA-372, not related to the OXA-48 family (43% amino acid identity) has been identified in a Citrobacter freundii isolate recovered from a hospital wastewater plant further expanding the diversity of class D carbapenemases recovered in Enterobacteriaceae. 10 In this study, we describe another novel plasmid-mediated transferable CHDL, named OXA-427, which was initially discovered in a Serratia marcescens isolate from a patient hospitalized in the ICU of a university hospital in Leuven, Belgium and subsequently detected in clinical isolates from eight additional patients in various Enterobacteriaceae species.
Materials and methods

Bacterial strains
From February 2012 to June 2014, 11 different MDR or XDR clinical Enterobacteriaceae isolates were recovered from various clinical samples from nine different patients (Table 1) . These isolates were submitted to the National Reference Laboratory (CHU UCL Namur, Yvoir, Belgium) as part of the national surveillance of carbapenemase-producing organisms.
The recovered isolates were identified to the species by MALDI-TOF mass spectrometry (MALDI Biotyper CA system; Bruker Daltonics, Billerica, MA, USA). Escherichia coli TOP10 (Life Technologies, Villebon-sur-Yvette, France) was used as the recipient strain of the electroporation experiment and E. coli DH10B (Fisher Scientific, Erembodegem, Belgium) was used for cloning experiments. Azide-resistant E. coli J53 was used as the recipient strain in conjugation experiments.
AST and phenotypic analysis
AST was performed by the disc diffusion method on Mueller-Hinton agar plates (BioRad, Marnes-La-Coquette, France) according to the CLSI guidelines.
11 Double-disc synergy testing for the detection of Ambler class A and/or class B and C b-lactamases was performed according to EUCAST guidelines for the detection of resistance mechanisms and specific resistances of clinical and/or epidemiological importance (http://www.eucast.org). MICs were determined by broth microdilution using Sensititre plates (Trek Diagnostic Systems, Cleveland, OH, USA). The carbapenemase activity was assessed using three different techniques: BYG Carba test, Carba NP test and MALDI-TOF mass spectrometry as previously described.
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Molecular detection of b-lactamase encoding genes and Sanger DNA sequencing Analysis of b-lactamase genes were performed by combining (i) CT102 array (Check-Points, Wageningen, the Netherlands), and (ii) several multiplex PCRsequencing assays targeting carbapenemases (bla VIM 
Immunochromatographic detection of OXA-48-like carbapenemases
The immunochromatographic OXA-48 K-SeT (R.E.S.I.S.T; Coris BioConcept, Gembloux, Belgium) for the detection of OXA-48-producing Enterobacteriaceae was performed using a single colony according to the manufacturer's instructions.
Cloning and expression of bla For cloning and expression, a fragment of 1213 bp including bla OXA-427 under the control of its own promoter and terminator was amplified with the primers OXA-427F02 (AGAAATGCCTCGACTTCGCTG)/OXA-427R01 (TCAACTC AGAATAAGCAGGAGG) and with the PCR polymerase Phusion V R (New England BioLabs, Ipswich, MA, USA). PCR product was resolved by 1.5% agarose gel electrophoresis and was purified using the Qiaquick gel extraction kit (Qiagen V R , Hilden, Germany). The PCR product was then ligated at the EcoRV site of pKSoriT vector, which was constructed by insertion of oriT from RP4 conjugative plasmid in the pBluescript II KS vector (Stratagene, La Jolla, CA, USA) (accession number X52326.1) and E. coli DH10B was transformed with the ligated product by heat shock. 17 Clones were selected on LB agar plates containing 5 mg/L chloramphenicol, 20 mM IPTG and 40 mg/L 5-bromo-4-chloro-3-indolyl-b-D-galactopyranoside (X-Gal).
Transformation and conjugation of the bla OXA-427 -carrying plasmid Plasmid DNA of the clinical isolates was extracted using the Kieser method. 18 E. coli NCTC 50192, harbouring four plasmids of 154, 66, 48 and 7 kb, was used as a plasmid size marker. Plasmid DNA was analysed by agarose gel electrophoresis. Direct transfer by electroporation into E. coli TOP10 of the b-lactam resistance markers was attempted with plasmid extract obtained from the index case (S. marcescens 20120206) and three other isolates (Enterobacter cloacae 20130678 and 20130723 and E. coli 20140187). Selection was performed on LB agar plates supplemented with ceftazidime 2 or 20 mg/L, or ampicillin 100 mg/L ! temocillin 30 mg/L.
Mating-out experiments were performed on solid and in liquid Brain Heart Infusion medium with E. cloacae 20130723 and azide-resistant E. coli J53. Selection of the transconjugants was performed on LB agar supplemented with azide and temocillin (30 mg/L). Counting of donor E. cloacae was performed on LB agar supplemented with gentamicin (50 mg/L). Transconjugants were analysed by PCR for the presence of bla OXA-427 as described above.
Whole plasmid sequencing
The plasmid of the transformant R222 obtained from E. cloacae 20130723 was fully sequenced and analysed. Purified plasmid from the selected electroporant was prepared with Qiagen V R plasmid mini kit (Qiagen V R , Hilden, Germany) according to manufacturer's instructions. The plasmid was then Table 1 . OXA-427, a plasmid-borne ESBL/carbapenemase from Aeromonas JAC fully sequenced (2%150 bp) with Illumina MiSeq using Nextera XT sample preparation kit (Illumina, San Diego, CA, USA). Raw data were analysed and assembled de novo using CLC Genomics Workbench 8.5.1 (CLC Bio, Aarhus, Denmark). The plasmid was finally closed using primers synthesized at the 5 0 and 3 0 end of the two largest contigs. Primers R222F01 (5 0 -GAACAACCAT TCCTTCAGCTC-3 0 )/R222R01 (5 0 -ACACCTGCGTCTTTGAGTGC-3 0 ) were used to close one gap and R222F02 (5 0 -ATCAGATCCCGCTCGAACTC-3 0 )/R222R05 (5 0 -TAATGAGATGGTCACTCCCTC-3 0 ) were used to close the second gap. To control the sequence of the second gap, two additional overlapping PCR/sequencing applications were performed with primer pairs R222F02/ R222R04 (5 0 -GACCTTCACGTAGGTTTCATC-3 0 ) and R222F04 (5 0 -GTACGCTGGT ACTGCAAATAC-3 0 )/R222R02 (5 0 -TCAAGCAAGGCACGGTAACG-3 0 ). The plasmid sequence was analysed with EMBOSS explorer (http://emboss.bioinfor matics.nl), by using the getorf tool to obtain the potential ORFs of the plasmid. The results obtained with EMBOSS were then analysed with BLAST (http://blast.ncbi.nlm.nih.gov/Blast.cgi) using blastx. The plasmid was then annotated using RAST (http://rast.nmpdr.org/). 19 In addition, the mobile genetic elements around bla OXA-427 were identified and annotated using ISFinder (https://www-is.biotoul.fr/), 20 or INTEGRALL databases (integrons, integrall.bio.ua.pt). 21 ResFinder from Center for Genomic Epidemiology was used to find resistance genes on the plasmid (https://cge.cbs.dtu.dk/services/ResFinder/).
Imipenem hydrolysis
The detection of imipenem hydrolysis on the clinical isolates and the transformants and clone was achieved with the BYG Carba test, 12 Carba NP test, 13 mass spectrometry 14 and modified Hodge test.
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Typing
The genetic relationship between the different isolates was determined by semi-automated repetitive sequence-based PCR (rep-PCR) (DiversiLab TM ; bioMérieux, Marcy L'Etoile, France) according to a previous validated method. 22 STs were determined by WGS on Illumina MiSeq using the publicly available MLST server at www.cbs.dtu.dk/services/MLST.
Nucleotide sequence accession number
The nt sequences of bla OXA-427 and the bla OXA-427 -bearing plasmid have been submitted to DDBJ/EMBL/GenBank nt sequence database under accession numbers KX827604 and KX86974, respectively.
Results
Characteristics of OXA-427-producing enterobacterial isolates
In March 2012, a 63 year old man was admitted to the ICU of a large tertiary care hospital in Leuven (UZ Gasthuisberg, Leuven, Belgium) after placement, in February 2012, of a left ventricular assist device complicated with multiple organ failure. The patient developed an episode of primary bloodstream infection of unknown source (culture of intravascular catheters remained negative) due to an MDR S. marcescens isolate (20120206), which was resistant to ampicillin, amoxicillin/clavulanic acid, piperacillin/tazobactam, extended-spectrum cephalosporins, all tested carbapenems and to temocillin (MIC .256 mg/L) ( Table 2 ). The patient was treated with meropenem 2 g/day and amikacin 500 mg q12h for 14 days and finally recovered.
The AST results were highly suggestive of an OXA-48-producing strain according to its resistance profile to carbapenem, piperacillin/tazobactam and temocillin associated with an ESBL. 23 However, the OXA-48 K-SeT assay (Coris BioConcept, Gembloux, Belgium) yielded a negative result and double-disc synergy testing did not reveal the presence of an additional class A and/or class B and C ESBLs. The BYG Carba test suggested the presence of a carbapenemase [signal value " 42 arbitrary units (AU); threshold for positivity 3.5 AU] while the Carba NP test remained negative after 2 h. The hydrolysis of imipenem was also confirmed by MALDI-TOF mass spectrometry, and modified Hodge test (data not shown). Routine multiplex PCR assays targeting the big five carbapenemases families (bla VIM , bla NDM , bla IMP , bla OXA-48 , bla KPC ), other lesscommon carbapenemases in Enterobacteriaceae (bla SMB , bla SME , bla DIM , bla GIM , bla SIM , bla SPM ) or carbapenemases of Acinetobacter and Pseudomonas (bla OXA-23 , bla OXA-24/40 , bla OXA-58 , bla OXA-143 , bla ) remained all negative. Additional molecular testing performed by PCR ligase detection using a commercial array (CT102; Check-Points, Wageningen, the Netherlands) also only detected a bla TEM WT gene (bla TEM-1 like ) not compatible with the results of the AST. Subsequently, from January 2013 to June 2014, 10 additional clinical isolates harbouring a similar antimicrobial resistance profile (resistance to temocillin and piperacillin/tazobactam associated with resistance or decreased susceptibility to carbapenems) [K. pneumoniae (n " 3), E. cloacae (n " 3), E. coli (n " 2), Klebsiella oxytoca (n " 1), Proteus rettgeri (n " 1)] were sent to the national reference centre for suspicion and confirmation/identification of a putative carbapenemase. The genetic relationship of the isolates was confirmed for the three E. cloacae and for the two K. pneumoniae originating from the ICU (20130517 and 20140349; .95% rep-PCR pattern similarity) while the K. pneumoniae 20130043 isolated earlier from a patient during a lung transplant consultancy showed an unrelated Diversilab rep-PCR profile (,70% pattern similarity; data not shown). This clonal relationship was confirmed by whole genome MLST ( Table 1) . The BYG Carba test was positive (signal values from 8 to 33 AU) for each isolate while the Carba NP test yielded a positive result for three of them. In all cases, all molecular tests failed to identify any known carbapenemase gene. The plasmids of the clinical isolates were extracted and their electrophoretic profiles revealed the presence of a similar plasmid of .154 kb (the largest plasmid size marker) (data not shown). Electroporation experiments yielded transformants harbouring the same size plasmid for each of the four clinical isolates tested. As an example, the E. coli TOP10 transformant obtained with plasmid extract from the E. cloacae 20130723 presented resistance to ampicillin, temocillin, piperacillin/tazobactam, ceftazidime and aztreonam, and decreased susceptibility to carbapenems (MIC of ertapenem 0.5 mg/L versus 0.06 mg/L for the recipient strain alone and MIC of imipenem 1 mg/L) ( Table 2 ). The carbapenemase activity (imipenem hydrolysis) of the transformant was confirmed using the BYG Carba test (signal value: 22 AU), mass spectrometry and modified Hodge test (data not shown). Transconjugants in E. coli J53 azide R were obtained on filter paper at the frequency of 10 #6 transconjugants per donor with the resistance profile similar to that obtained for the electroporant (Table 2) .
This plasmid was then purified and fully sequenced revealing a size of 177037 bp. BLAST analysis of this sequence in GenBank confirmed the presence of bla TEM-1b gene and of a new class D b-lactamase gene named bla OXA-427 (accession number: KX86974). ResFinder-2.1 Server detects bla TEM-1B with 100% identity and ampH of Aeromonas hydrophila with 83.62% identity (accession number HQ586946), this latter being not detected using the default cut-off of 90% identity. (Figure 1 ). It presents 99% amino acid identity with the chromosomal AmpS of Aeromonas media WS (accession number AHX63134) (difference by two amino acids: M211T and K230Q, DBL numbering). 24 According to the three other genome sequence data of A. media (ARB13, ARB20 and CECT4232) available on GenBank, an identical class D b-lactamase (accession number WP043131267) was detected in ARB13 and ARB20. This variant presents three amino acid differences from OXA-427 (L42M, H134R and M211T, DBL numbering). OXA-427 also presents 89% amino acid identity with the chromosomal AmpS (accession number AHE51634) of A. hydrophila (difference by 27 amino acids). Compared with other class D b-lactamases reported in the Lahey Clinics b-lactamase data bank (http://www.lahey.org/ studies/other.asp), OXA-427 is more closely related to OXA-12 OXA-427, a plasmid-borne ESBL/carbapenemase from Aeromonas JAC from Aeromonas sobria (77% amino acid identity), 25 than to other OXA variants (39%, 35% and 29% amino acid identity with OXA-9, OXA-1 and OXA-48, respectively). Moreover OXA-427 shares only 24% identity with OXA-23, OXA-24/40 and OXA-58 CHDLs and 22% with OXA-372 (data not shown).
The OXA-427 cloned in E. coli DH10B conferred resistance to penicillins, including temocillin, ceftazidime and aztreonam, and to ertapenem ( Table 2) . OXA-427 does not confer resistance to cefotaxime. In addition, based on the combination disc test using ceftazidime and ceftazidime/clavulanate 30/10 lg, OXA-427 expressed in the transformant seems partially inhibited by clavulanic acid (diameter with ceftazidime " 6 mm and with ceftazidime/clavulanate " 14 mm; data not shown).
Genetic environment of bla OXA-427 gene
The bla OXA-427 gene was located on a 177037 bp type 2 A/C 2 plasmid comprising 169 ORFs of .100 amino acids. 26 Its 129.2 kb conserved scaffold presents 99% nt identities with sequenced plasmid R55 (accession number: JQ010984; Figure 2a) . 27 The pOXA-427 plasmid includes two resistance islands (RIs); the first, ARI-B, is 2824 kb and includes sul2 gene coding for the sulphonamide resistance, one usual signature differentiating A/C 2 plasmid from A/C 1 plasmid (Figure 2b ). ARI-B is located at the same position as usually observed in A/C 2 plasmid, 26 29334 nt downstream of repA gene. A second RI (Figure 2c ), containing bla OXA-427 , is 45.0 kb long and inserted 115339 nt downstream of repA, the same position as the RI of plasmid R55. In brief, this RI is bracketed by two duplicated inverted mercury resistance regions identical to those described in the plasmid R55. It also contains a pemKI type II toxin-antitoxin system, and various transposons and ISs (Figure 2c ). It contains, in addition to bla OXA-427 , three resistance genes, strA and strB conferring resistance to streptomycin and a bla TEM-1b b-lactamase gene. The close genetic context of bla OXA-427 is presented in Figure 2(d) . The bla OXA-427 gene is bracketed by two chromosomal sequences (59 nt upstream and 50 nt downstream) identical to the sequences bracketing bla AmpS in A. media WS further suggesting the transfer of this gene from this species. bla OXA-427 is not located on a gene cassette as no attC site could be found in the vicinity of the gene. In addition, the integrase gene intI1 is truncated at its 5 0 end, erasing the initiating ATG codon. The molecular process leading to the insertion of this specific bla OXA-427 DNA into the plasmid remains to be clarified.
Discussion
In this study, we have detected a new class D carbapenemase, OXA-427, which was recovered sporadically from various clinical specimens of nine patients hospitalized in the ICU and nephrology ward of a large tertiary care hospital in Belgium. The bla OXA-427 was located on a type 2 A/C 2 plasmid of 177 kb and was detected across different species over a 2 year period. This new variant differs from all currently known class D b-lactamases such as OXA-48 or OXA-372 usually found in Enterobacteriaceae or those (OXA-23, -24/40 or -58) found in Acinetobacter spp. The bla OXA-427 gene seems to have been transferred to clinical strains from A. media WS by a mechanism that remains to be elucidated. A. media WS is a high-melanin-yielding bacterium that was first described in 1997 in China. 28 This newly isolated species was reported as presenting industrial interest because of its melanin production, which presents the potential to be used as a photoprotective agent for bioinsecticides. The draft genome sequence of the high-melaninyielding A. media WS strain genome was published in 2012 (accession number: CP007567.1). 29 The conditions under which this new OXA-427 CHDL was discovered highlight the interest of using screening tests based on carbapenem hydrolysis for the detection of carbapenemase-producing Enterobacteriaceae. In particular, the BYG Carba test repeatedly suggested the presence of a carbapenemase while it could not be identified by the set of molecular tests used in our laboratory. On the other hand, the Carba NP test, detected the presence of a carbapenemase in three of the OXA-427-producing isolates, which further suggests that OXA-427 is a carbapenemase. The imipenem hydrolysis of OXA-427 was also confirmed by mass spectrometry and modified Hodge test. As evidenced by whole plasmid sequencing, bla OXA-427 is located on an A/C 2 plasmid. IncA/C plasmids are large, broad host range conjugative plasmids presenting a common scaffold of 128-130 kb in which RIs are inserted. A/C 2 plasmids are of high clinical importance as these represent some of the main vehicles of the dissemination of bla NDM-1 suggesting the capability of this plasmid to disseminate by conjugation. 26 The ability of dissemination of pOXA-427 is also suggested by the fact that bla OXA-427 was detected in different Enterobacteriaceae species recovered at the same hospital over more than 2 years and by obtaining transconjugants. Compared with R55 plasmid, the RI of pOXA-427 shared the two mercuric resistance operons and the sequences downstream bla OXA-427 from IS1326 to the end of the RI. OXA-427, a plasmid-borne ESBL/carbapenemase from Aeromonas JAC Interestingly, the 45.0 kb RI includes a toxin-antitoxin system that could stabilize the plasmid and promote its persistence in the bacterial cell. 27 The b-lactam resistance profile conferred by OXA-427 is similar to the one of an OXA-48-like carbapenemase (including temocillin resistance) having acquired the capability to hydrolyse extended-spectrum b-lactams, particularly aztreonam and ceftazidime but not cefotaxime. Its ability to hydrolyse carbapenems is suggested by the resistance profile of the clinical strains, transformants/transconjugants, clone and by the positive results obtained with different imipenem hydrolysis tests.
In conclusion, we identified OXA-427, a new ESBL and carbapenemase class D b-lactamase. The plasmid pOXA-427 was found to cause horizontal and vertical transfer so far detected in a single hospital in Belgium. The presence of OXA-427 was initially evidenced by the BYG Carba test based on imipenem hydrolysis. bla OXA-427 could not be detected by molecular tests, as its sequence is very different from other currently reported OXAcarbapenemases. This underlines the interest of the imipenem hydrolysis base test for the detection of the presence of carbapenemase. We strongly encourage the different experts to screen their WGS databases for the presence of this gene setting the cutoff for identity in Resfinder to 80%.
